GSK FULFILS Goals, CDXC Sinks On Short Seller Report, LPTN Up On Defense Grant

Shares of ChromaDex Corp. (CDXC) plunged over 42% on Monday, following a report by short seller Bleecker Street Research, which details allegations of stock promotion and fraud.

from RTT - Biotech http://ift.tt/28KqmUd
via IFTTT